ENDRA Life Sciences (NDRA) Depreciation & Amortization (CF) (2016 - 2026)
ENDRA Life Sciences (NDRA) posted quarterly Depreciation & Amortization (CF) of $9492.0 for Q1 2026, down 31.15% YoY from $13786.0 in Q1 2025, and down 6.18% sequentially from $10117.0 in Q4 2025.
ENDRA Life Sciences (NDRA) Depreciation & Amortization (CF) (2016 - 2026) Analysis & Trends
ENDRA Life Sciences has disclosed Depreciation & Amortization (CF) across 11 years of filings, most recently posting $9492.0 for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) fell 31.15% year-over-year to $9492.0; the TTM figure through Mar 2026 stood at $39751.0 (down 11.62% YoY), while the FY2025 annual figure was $44045.0, down 5.26% from the prior year.
- Depreciation & Amortization (CF) eased to $9492.0 in Q1 2026, from $10117.0 in the prior quarter.
- Over the last five years, Depreciation & Amortization (CF) for NDRA reached as high as $35265.0 in Q2 2023 and fell as low as $8693.0 in Q2 2024.
- The 5-year median for Depreciation & Amortization (CF) is $15300.0 (2024), against an average of $18847.8.
- Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) soared 81.3% — and 2024, when it plunged 75.35%.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $32129.0 in 2022, then sank by 31.88% to $21887.0 in 2023, then plunged by 49.74% to $11000.0 in 2024, then dropped by 8.03% to $10117.0 in 2025, then fell by 6.18% to $9492.0 in 2026.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $9492.0, $10117.0, and $10786.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 36.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 306.00 Mn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 193.00 Mn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 37.68 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 14.52 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 67.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 288.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 51.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 13.16 Mn |
| 10 | ENDRA Life Sciences | 5.95 Mn | 5.59 Mn | - | 9,492.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9,492.00 |
| Mar 31, 2026 | 9,492.00 |
| Dec 31, 2025 | 10,117.00 |
| Dec 31, 2025 | 10,117.00 |
| Sep 30, 2025 | 10,786.00 |
| Sep 30, 2025 | 10,786.00 |
| Jun 30, 2025 | 9,356.00 |
| Jun 30, 2025 | 9,356.00 |
| Mar 31, 2025 | 13,786.00 |
| Mar 31, 2025 | 13,786.00 |
| Dec 31, 2024 | 11,000.00 |
| Dec 31, 2024 | 11,000.00 |
| Sep 30, 2024 | 11,496.00 |
| Sep 30, 2024 | 11,496.00 |
| Jun 30, 2024 | 8,693.00 |
| Jun 30, 2024 | 8,693.00 |
| Mar 31, 2024 | 15,300.00 |
| Mar 31, 2024 | 15,300.00 |
| Dec 31, 2023 | 21,887.00 |
| Dec 31, 2023 | 21,887.00 |